Anaplastic oligodendroglioma

From WikiMD's WELLNESSPEDIA


Anaplastic Oligodendroglioma
Synonyms N/A
Pronounce N/A
Specialty N/A
Symptoms Headache, seizures, neurological deficits
Complications N/A
Onset Adulthood
Duration Chronic
Types N/A
Causes Genetic mutations
Risks Family history, radiation exposure
Diagnosis MRI, biopsy
Differential diagnosis N/A
Prevention N/A
Treatment Surgery, radiation therapy, chemotherapy
Medication N/A
Prognosis Variable
Frequency Rare
Deaths N/A


Anaplastic oligodendroglioma is a rare and aggressive type of brain tumor that originates from oligodendrocytes, which are cells in the central nervous system responsible for producing myelin. This tumor is classified as a World Health Organization (WHO) grade III glioma, indicating a high degree of malignancy.

Symptoms[edit]

Patients with anaplastic oligodendroglioma may experience a variety of symptoms depending on the tumor's location and size. Common symptoms include:

Causes[edit]

The exact cause of anaplastic oligodendroglioma is not well understood, but it is believed to involve genetic mutations. Common genetic alterations associated with this tumor include co-deletion of chromosomes 1p and 19q and mutations in the IDH1 or IDH2 genes.

Diagnosis[edit]

Diagnosis of anaplastic oligodendroglioma typically involves imaging studies such as magnetic resonance imaging (MRI) to assess the tumor's location and characteristics. A biopsy is often performed to obtain a tissue sample for histological examination and genetic testing.

Treatment[edit]

Treatment options for anaplastic oligodendroglioma may include:

Prognosis[edit]

The prognosis for patients with anaplastic oligodendroglioma varies based on factors such as the extent of surgical resection, genetic profile of the tumor, and response to treatment. Tumors with 1p/19q co-deletion generally have a better prognosis.

See also[edit]

References[edit]


External links[edit]